Elevated toll-like receptor 3 inhibits pancreatic β-cell proliferation through G1 phase cell cycle arrest

Molecular and Cellular Endocrinology

Volumn 377, Issue 1-2, 2013, Pages 112-122

  Wang, Yi ^a   Wu, HuiWen ^a   Gao, LiLi ^a   Chen, ShanShan ^a   Gu, LiZe ^a   Ding, ZhengZheng ^a   Guo, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cell; Arrest; Glucolipotoxicity; Proliferation; TLR3

Indexed keywords

CYCLIN D1; CYCLIN D2; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LEVEL; CELL LOSS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DEGRADATION KINETICS; G1 PHASE CELL CYCLE CHECKPOINT; GLUCOLIPOTOXICITY; GROWTH INHIBITION; LIPOTOXICITY; MALE; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84881116306     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.07.003     Document Type: Article

References (64)

1. Ackermann A.M., Gannon M. Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion. J. Mol. Endocrinol. 2007, 38:193-206.
2. Ackermann, Misfeldt A., Costa R.H., Gannon M. Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes 2008, 57:3069-3077.
3. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
4. Al-Masri M., Krishnamurthy M., Li J., Fellows G.F., Dong H.H., Goodyer C.G., Wang R. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas. Diabetologia 2010, 53:699-711.
5. Baggio L.L., Drucker D.J. Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu. Rev. Med. 2006, 57:265-281.
6. Börgeson E., Godson C. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front Immunol. 2012, 3:1-10.
7. Bouwens L., Rooman I. Regulation of pancreatic beta-cell mass. Physiol. Rev. 2005, 85:1255-1270.
8. Bu H.Q., Luo J., Chen H., Zhang J.H., Li H.H., Guo H.C., Wang Z.H., Lin S.Z. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. Int. J. Oncol. 2012, 41:949-958.
9. Burns C.J., Squires P.E., Persaud S.J. Signaling through the p38 and p42/44 mitogen-activated families of protein kinases in pancreatic beta-cell proliferation. Biochem. Biophys. Res. Commun. 2000, 268:541-546.
10. Casanovas O., Miro F., Estanyol J.M., Itarte E., Agell N., Bachs O. Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 2000, 275:35091-35097.
11. Casanovas O., Jaumot M., Paules A.B., Agell N., Bachs O. P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation. Oncogene 2004, 23:7537-7544.
12. Chen G., Bower K.A., Ma C., Fang S., Thiele C.J., Luo J. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J. 2004, 18:1162-1164.
13. Cnop M. Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes. Biochem. Soc. Trans. 2008, 36:348-352.
14. Dasu M.R., Devaraj S., Park S., Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010, 33:861-868.
15. Diehl J.A., Zindy F., Sherr C.J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 1997, 11:957-972.
16. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase- 3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998, 12:3499-3511.
17. Dogusan Z., Garcia M., Flamez D., Alexopoulou L., Goldman M., Gysemans C., Mathieu C., Libert C., Eizirik D.L., Rasschaert J. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 2008, 57:1236-1245.
18. Doyle S.E., O'Connell R.M., Miranda G.A., Vaidya S.A., Chow E.K., Liu P.T., Suzuki S., Suzuki N., Modlin R.L., Yeh W.C., Lane T.F., Cheng G. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 2004, 199:81-90.
19. Ehses J.A., Meier D.T., Wueest S., Rytka J., Boller S., Wielinga P.Y., Schraenen A., Lemaire K., Debray S., Van, Lommel L., Pospisilik J.A., Tschopp O., Schultze S.M., Malipiero U., Esterbauer H., Ellingsgaard H., Rutti S., Schuit F.C., Lutz T.A., Boni-Schnetzler M., Konrad D., Donath M.Y. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 2010, 53:1795-1806.
20. Fatrai S., Elghazi L., Balcazar N., Cras-Meneur C., Krits I., Kiyokawa H., Bernal-Mizrachi E. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 2006, 55:318-325.
21. Fiaschi-Taesch N.M., Salim F., Kleinberger J., Troxell R., Cozar-Castellano I., Selk K., Cherok E., Takane K.K., Scott D.K., Stewart A.F. Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6. Diabetes 2010, 59:1926-1936.
22. Flodstrom-Tullberg M., Hultcrantz M., Stotland A., Maday A., Tsai D., Fine C., Williams B., Silverman R., Sarvetnick N. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol. 2005, 174:1171-1177.
23. Fresno M., Alvarez R., Cuesta N. Toll-like receptors, inflammation, metabolism and obesity. Arch. Physiol. Biochem. 2011, 117:151-164.
24. Guo J., Zhu J.X., Deng X.H., Hu X.H., Zhao J., Sun Y.J., Han X. Palmitate-induced inhibition of insulin gene expression in rat islet β-cells involves the ceramide transport protein. Cell Physiol. Biochem. 2010, 26:717-728.
25. Guthalu, Kondegowda N., Joshi-Gokhale S., Harb G., Williams K., Zhang X.Y., Takane K.K., Zhang P., Scott D.K., Stewart A.F., Garcia-Ocaña A., Vasavada R.C. Parathyroid hormone-related protein enhances human ß-cell proliferation and function with associated induction of cyclin-dependent kinase 2 and cyclin E expression. Diabetes 2010, 59:3131-3138.
26. Han X., Sun Y., Scott S., Bleich D. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes 2001, 50:1047-1055.
27. Harashima N., Inao T., Imamura R., Okano S., Suda T., Harada M. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Cancer Immunol. Immunother. 2011, 61:667-676.
28. Heit J.J., Karnik S.K., Kim S.K. Intrinsic regulators of pancreatic beta-cell proliferation. Annu. Rev. Cell Dev. Biol. 2006, 22:311-338.
29. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
30. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 2008, 8:923-934.
31. Hutton M.J., Soukhatcheva G., Johnson J.D., Verchere C.B. Role of the TLR signaling molecule TRIF in beta-cell function and glucose homeostasis. Islets 2010, 2:104-111.
32. Karslioglu E., Kleinberger J.W., Salim F.G., Cox A.E., Takane K.K., Scott D.K., Stewart A.F. CMyc is a principal upstream driver of beta-cell proliferation in rat insulinoma cell lines and is an effective mediator of human beta-cell replication. Mol. Endocrinol. 2011, 25:1760-1772.
33. Kida A., Kakihana K., Kotani S., Kurosu T., Miura O. Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells. Oncogene 2007, 26:6630-6640.
34. Kim H., Jo C., Jang B.G., Oh U., Jo S.A. Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level. Cell Signal 2008, 20:120-129.
35. Kim T.H., Choi S.E., Ha E.S., Jung J.G., Han S.J., Kim H.J., Kim D.J., Kang Y., Lee K.W. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol. 2013, 50:189-200.
36. Kushner J.A., Ciemerych M.A., Sicinska E., Wartschow L.M., Teta M., Long S.Y., Sicinski P., White M.F. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol. Cell Biol. 2005, 25:3752-3762.
37. Lathia J.D., Okun E., Tang S.C., Griffioen K., Cheng A., Mughal M.R., Laryea G., Selvaraj P.K., ffrench-Constant C., Magnus T., Arumugam T.V., Mattson M.P. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J. Neurosci. 2008, 28:13978-13984.
38. Li J., Quirt J., Do H.Q., Lyte K., Fellows F., Goodyer C.G., Wang R. Expression of c-Kit receptor tyrosine kinase and effect on beta-cell development in the human fetal pancreas. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E475-E483.
39. Li M., Dou L., Jiao J., Lu Y., Guo H.B., Man Y., Wang S., Li J. NADPH oxidase 2-derived reactive oxygen species are involved in dysfunction and apoptosis of pancreatic β-cells induced by low density lipoprotein. Cell Physiol. Biochem. 2012, 30:439-449.
40. Lien E., Zipris D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr. Mol. Med. 2009, 9:52-68.
41. Maedler K., Oberholzer J., Bucher P., Spinas G.A., Donath M.Y. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreaticbeta-cell turnover and function. Diabetes 2003, 52:726-733.
42. Malicet C., Lesavre N., Vasseur S., Iovanna J.L. P8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth. Mol. Cancer 2003, 2:37.
43. Martinez S.C., Tanabe K., Cras-Meneur C., Abumrad N.A., Bernal-Mizrachi E., Permutt M.A. Inhibition of foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 2008, 57:846-859.
44. Masiello P. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int. J. Biochem. Cell Biol. 2006, 38:873-893.
45. Matsumoto M., Funami K., Oshiumi H., Seya T. Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol. Immunol. 2004, 48:147-154.
46. Meng Z.X., Nie J., Ling J.J., Sun J.X., Zhu Y.X., Gao L., Lv J.H., Zhu D.Y., Sun Y.J., Han X. Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 2009, 52:125-135.
47. Nakamura T., Furuhashi M., Li P., Cao H., Tuncman G., Sonenberg N., Gorgun C.Z., Hotamisligil G.S. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 2010, 140:338-348.
48. Pascoe J., Hollern D., Stamateris R., Abbasi M., Romano L.C., Zou B., O'Donnell C.P., Garcia-Ocana A., Alonso L.C. Free fatty acids block glucose-induced β-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes 2012, 61:632-641.
49. Poitout V., Roberson R.P. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr. Rev. 2008, 29:351-366.
50. Raven J.F., Baltzis D., Wang S., Mounir Z., Papadakis A.I., Gao H.Q., Koromilas A.E. PKR and PKR-like endoplasmic reticulum kinase induce the proteasome-dependent degradation of cyclin D1 via a mechanism requiring eukaryotic initiation factor 2alpha phosphorylation. J. Biol. Chem. 2008, 283:3097-3108.
51. Rodgers R.J., Tschöp M.H., Wilding J.P. Anti-obesity drugs: past, present and future. Dis. Model. Mech. 2012, 5:621-626.
52. Sarkar S.N., Peters K.L., Elco C.P., Sakamoto S., Pal S., Sen G.C. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 2004, 11:1060-1067.
53. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes 1999, 13:1501-1512.
54. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest 2006, 116:3015-3025.
55. Shiozaki A., Otsuji E., Marunaka Y. Intracellular chloride regulates the G(1)/S cell cycle progression in gastric cancer cells. World J. Gastrointest. Oncol. 2011, 15:119-122.
56. Song W.J., Schreiber W.E., Zhong E., Liu F.F., Kornfeld B.D., Wondisford F.E., Hussain M.A. Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes 2008, 57:2371-2381.
57. Stefanov T., Temelkova-Kurktschiev T., Koehler C., Henkel E., Schaper F., Hanefeld M. Association of physical activity with insulin resistance, subclinical inflammation, coagulation, and fibrinolytic biomarkers among population at high risk for type 2 diabetes. Folia. Med. (Plovdiv.) 2012, 54:32-39.
58. Swiecki M., McCartney S.A., Wang Y., Colonna M. TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes. J. Leukoc. Biol. 2011, 90:691-701.
59. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004, 16:3-9.
60. Velazquez-Garcia S., Valle S., Rosa T.C., Takane K.K., Demirci C., Alvarez-Perez J.C., Mellado-Gil J.M., Ernst S., Scott D.K., Vasavada R.C., Alonso L.C., Garcia-Ocaña A. Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and induces β-cell expansion via mTOR activation. Diabetes 2011, 60:2546-2559.
61. Wu L.H., Huang C.C., Adhikarakunnathu S., San Mateo L.R., Duffy K.E., Rafferty P., Bugelski P., Raymond H., Deutsch H., Picha K., Ward C.K., Alexoupolou L., Flavell R.A., Mbow M.L., Susulic V.S. Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice. Metabolism 2012, 61:1633-1645.
62. Yesil P., Lammert E. Islet dynamics: a glimpse at beta cell proliferation. Histol. Histopathol. 2008, 23:883-895.
63. Yu X.J., Han Q.B., Wen Z.S., Ma L., Gao J., Zhou G.B. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells. Cancer Lett. 2012, 22:185-194.
64. Zimmer S., Steinmetz M., Asdonk T., Motz I., Coch C., Hartmann E., Barchet W., Wassmann S., Hartmann G., Nickenig G. Activation of endothelial toll-like receptor 3 impairs endothelial function. Circ. Res. 2011, 108:1358-1366.